Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-13

Clinical Trial Update: LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation. [NA]

View source ↗

Summary

A clinical trial is recruiting to compare left atrial appendage clipping versus non-vitamin K antagonist oral anticoagulants for stroke prevention in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Left atrial appendage occlusion device (Left atrial appendage occluder / clipping device)
  • Non-vitamin K antagonist oral anticoagulants (NOACs) (Non-vitamin K antagonist oral anticoagulants)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Non-paroxysmal Atrial Fibrillation | NA | Status: RECRUITING